Project Number 2R56AG047992-07A1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Long-Term Nicotine Treatment of Mild Cognitive Impairment Research Categorization CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator NEWHOUSE, PAUL A. Principal Investigator First Name PAUL A. Principal Investigator Last Name NEWHOUSE Awardee Organization VANDERBILT UNIVERSITY MEDICAL CENTER Awardee State Tennessee Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-878: Late Stage Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) FY Overall Cost $6,088,879 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
